Multi-Size Pack 5mg 10mg 30mg 60mg Tirzepatide Research Grade Peptide Powder
TDS 2101 Inquiries
2023788-19-2
Reagent Grade
98%
shenzhen
rxc
5mg 10mg 15mg 20mg 30mg 40mg 50mg 60mg 80mg 100mg
2026-08-09
peptide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Certificates-
TDS
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
peptide
-
Location:
south road and north road
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Inquiry History2101 Inquiries
Country Product Purchase Quantity Date Posted
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026
United States
Tirzepatide
50 MG Oct 20, 2026
Spain
tirzepatide
20 MG Oct 19, 2026
United States
tirzepatide
30 MG Oct 19, 2026
Philippines
tirzepatide
40 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
Tirzepatide
20 MG Oct 19, 2026
United States
Tirzepatide
300 MG Oct 19, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Zirconium Sulfate Hydrate CAS 14644-61-2
Industrial Grade / 99%
-
-
-
-
Malic acid 99.99%
Food Grade / 99.99%
-
-
-
-
Factory Industrial Grade EDTA 4na Powder EDTA Tetrasodium Salt
Food Grade / 99%
-
-
-
-
High Quality SLS 70 Sodium Laureth Sulfate CAS 3088-31-1
Industrial Grade / 70%
-
-
-
-
Polyethylene Glycol Monomethallyl Ether HPEG 2400 CAS 31497-33-3
Industrial Grade / 99.9%
-
-
-
-
Epoxy Resin HD128 99.9% liquid 128
Industrial Grade / 99.9%
-
